OTC/SmallCap IRW

Cipla Gulf Expands Partnership with Alvotech for Commercialization of Biosimilars in Australia and New Zealand

MUMBAI, India, March 2, 2021 /PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as "Cipla" today announced that its subsidiary, Cipla Gulf FZ LCC ("Cipla Gulf') is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines inAustra...

2021-03-02 22:05 1256

Kazia Licenses Cantrixil, a Clinical-stage, First-in-class Ovarian Cancer Drug Candidate, to Oasmia Pharmacetical AB

SYDNEY, March 2, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has entered into an exclusive worldwide license agreement with Oasmia Pharmaceutical AB (STO: OASM), an innovation-focuse...

2021-03-02 07:00 1419

BioVaxys Expanding Technology Platform To Address Emerging SARS-CoV-2 Variants

BVX-0320 and Covid-T to have capability to address UK, Brazilian and South African Virus Variants VANCOUVER, B.C., March 1, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF)("BioVaxys"), the world leader in haptenized protein vaccines for antiviral and cancer app...

2021-03-01 21:00 3045

Announcement of change in the total number of votes in AB SKF

GOTHENBURG, Sweden, Feb. 26, 2021 /PRNewswire/ -- Due to a conversion of shares from Series A to Series B in accordance with AB SKF's Articles of Association, the Company confirms the following. As per 26 February, the Company's share capital amounts to SEK 1,138,377,670 and the total number of ...

2021-02-26 17:27 4112

Electrolux publishes 2020 Annual Report

STOCKHOLM, Feb. 25, 2021 /PRNewswire/ -- Electrolux Annual Report for 2020 has been published on the Group's website as of today. The Annual Report can be downloaded in pdf format here and will be distributed inmid-March 2021 to shareholders who have requested it. "The coronavirus pandemic in 20...

2021-02-25 15:53 3858

Elekta appoints Johan Adebäck as Chief Financial Officer

STOCKHOLM, Feb. 25, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that Johan Adebäck has been appointed as permanent Chief Financial Officer with immediate effect. He has held the position of Acting CFO sinceJune 2, 2020. Prior to the Acting CFO position, Johan Adebäck had been Group Tr...

2021-02-25 14:52 3897

Notice of Ericsson's Annual General Meeting 2021

STOCKHOLM, Feb. 23, 2021 /PRNewswire/ -- The Annual General Meeting of shareholders of Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC) will be held on Tuesday, March 30, 2021. Due to the COVID-19 pandemic, the Board of Directors has decided that the Annual General Meeting of shareholders 2021 will...

2021-02-23 16:01 2213

BioVaxys Announces Appointment To Its Scientific Advisory Board

VANCOUVER, B.C., Feb. 22, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys"), a biotechnology company that is advancing viral and oncology vaccine platforms as well as immuno-diagnostic products, today announced the appointment of Kartik Chandran Ph.D....

2021-02-22 21:00 783

China Telecom Honored with Three Awards including "Platinum Award", "Best CEO" and "Best Investor Relations Team" by The Asset

HONG KONG, Feb. 22, 2021 /PRNewswire/ -- China Telecom Corporation Limited ("China Telecom" or "the Company"; HKEx: 00728; NYSE: CHA) is pleased to announce that the Company was accredited with "Platinum Award – Excellence in Environmental, Social and Governance" in the poll of "ESG Corporate Awa...

2021-02-22 16:30 2857

Sasol delivered a good set of results for the six months ended 31 December 2020

JOHANNESBURG, Feb. 22, 2021 /PRNewswire/ -- Sasol delivered a good set of results for the six months ended31 December 2020. Our earnings increased by more than 100% to R15,3 billion from R4,5 billion in the prior period. Despite a 23% decrease in the rand/barrel oil price, our adjusted EBITDA de...

2021-02-22 15:21 1843

Elekta establishes office in Egypt to meet growing need for precision radiation medicine

STOCKHOLM, Feb. 22, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it will establish a permanent office inCairo, Egypt, to address the shortage of radiotherapy delivery systems and software solutions that play an integral part in treating cancer and brain disorders. To strengthen i...

2021-02-22 15:03 5581

BioVaxys and BioElpida Sign Term Sheet for Clinical Grade BVX-0918A Bio-production

SIGNIFICANT ADVANCEMENT TOWARDS LAUNCH OF PHASE I OVARIAN CANCER VACCINE TRIAL VANCOUVER, BC, Feb. 18, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys" or "Company") announced today that it has signed a Term Sheet ("Term Sheet") with BioElpida S.A.S. ...

2021-02-18 21:00 3786

Crunchfish enrolled to leading international payment network's partner program

STOCKHOLM, Feb. 18, 2021 /PRNewswire/ -- Crunchfish AB ("Crunchfish") announces its enrolment into a leading international payment network's partner program with its Digital Cash solutions. As a technology partner, Crunchfish will get access to specifications and toolkits enabling integration wit...

2021-02-18 16:12 6643

Nel ASA: Fourth quarter 2020 financial results

OSLO, Norway, Feb. 18, 2021 /PRNewswire/ -- Nel ASA (Nel) reported revenues of NOK 229.1 million in the fourth quarter of 2020, up from NOK 175.9 million in the same quarter of 2019 and an EBITDA of negativeNOK 96.2 million (Q4 2019: -41.7) incl. one-offs, ramp-up cost and aNOK 20 million provisi...

2021-02-18 14:59 4043

RedHill Biopharma Announces First Patient Dosed in U.S. Phase 2/3 COVID-19 Outpatient Study with RHB-107

- The U.S. Phase 2/3 study with once-daily, orally-administered RHB-107 (upamostat) evaluates treatment of patients with symptomatic COVID-19 who do not require hospitalization - the vast majority of patients - RHB-107 is a novel serine protease inhibitor targeting human cell factors involved in...

2021-02-17 20:00 2101

Notice convening the Annual General Meeting of AB Electrolux

STOCKHOLM, Feb. 15, 2021 /PRNewswire/ -- The shareholders of AB Electrolux, reg. no. 556009-4178, are hereby given notice of the Annual General Meeting to be held onThursday, March 25, 2021. Due to the coronavirus, the Board of Directors has decided that the Annual General Meeting should be cond...

2021-02-15 20:42 3735

Digital Cash enables global interoperability for payment services

STOCKHOLM, Feb. 15, 2021 /PRNewswire/ -- Crunchfish is a technical pioneer within digital payment with Digital Cash that settles payments in two steps, first offline and then online. This enables payments that always work and can also be made with preserved integrity. Digital Cash is extremely fl...

2021-02-15 20:26 6331

Össur will be carbon neutral in 2021

REYKJAVIK, Iceland, Feb. 10, 2021 /PRNewswire/ -- Össur (Nasdaq: OSSR), a global leader in the orthotics and prosthetics (O&P) industry with a rich history of ground-breaking innovations, announced today that the company will be carbon neutral in 2021, its 50th anniversary year. Originally founde...

2021-02-10 23:58 5519

BioVaxys and Procare Health Announce Broad Co-Development, Joint Commercialization and Marketing Collaboration for Cancer and Viral Vaccines

VANCOUVER, BC and BARCELONA, Spain, Feb. 10, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC:L MNGF)("BioVaxys"), the world leader in haptenized protein vaccines for antiviral and cancer applications, and Procare Health Iberia, S.L., ofBarcelona, Spain ("Procare Health"...

2021-02-10 21:26 2663

Elekta's ProKnow to help standardize radiotherapy for veterans

Cloud-based ProKnow will enable peer review across Veterans Affairs network ATLANTA, Feb. 10, 2021 /PRNewswire/ -- Elekta announced today that the United States Department of Veterans Affairs (VA) National Radiation Oncology Program is poised to pair its major radiotherapy quality program with El...

2021-02-10 21:25 5384
12345 ... 34